Kolosis BIO to Exhibit at the 2022 Montana Orthopedic Society Meeting
Kolosis BIO, a privately-held pure-play orthobiologics company, announces its support of the 2022 Montana Orthopedic Society meeting, January 14-16 at the Yellowstone Conference Center in Big Sky, Montana.
Kolosis BIO Announces Release of Scientific White Paper
Salt Lake City, Utah – Kolosis BIO, a privately-held pure-play orthobiologics company, announced today the completion and release of a scientific white paper studying the effects of terminal sterilization on allograft tissues.
Kolosis BIO to Exhibit at the 2021 Society of Military Orthopedic Surgeons
Salt Lake City, Utah. – Kolosis BIO, a privately-held pure-play orthobiologics company, announces its support of the 2021 Society of Military Orthopedic Surgeons, December 14-17 at the Resort at Squaw Creek in Olympic Valley, California.
Kolosis BIO Appoints Maxwell Hunter as its Chief Operations Officer
Salt Lake City, Utah – Kolosis BIO, a privately-held pure-play orthobiologics company, announced today the appointment of Maxwell Hunter as the company’s Chief Operating Officer.
Kolosis BIO Announces the Appointment of Keegan Begley as President
Salt Lake City, Utah – Kolosis BIO, a privately-held pure-play orthobiologics company, announced today the appointment of Keegan Begley as the company’s President.
Kolosis BIO and MTF Biologics Announce Launch of Kore Fiber™
SALT LAKE CITY, Utah–(BUSINESS WIRE)—Kolosis BIO, LLC (Kolosis) announced today, in collaboration with MTF Biologics (MTF), the market release of Kore Fiber™, an exclusively processed demineralized cortical fiber allograft for Kolosis.